How to Win an Antitrust Merger Trial: Lessons from FTC v Evonik PeroxyChem

The U.S. antitrust agencies in recent years have aggressively sought to block mergers they view as anticompetitive, racking up an impressive win rate. However, earlier this year chemical manufacturers PeroxyChem – represented by Dechert LLP – and Evonik successfully defended the FTC’s challenge in federal court to their proposed merger, which has now closed.

In this webinar, Dechert’s Mike Cowie, James Fishkin, Shari Ross Lahlou and Brian Rafkin discuss lessons learned from the Evonik/PeroxyChem trial and examine strategies that companies can use to defeat a merger challenge, including early identification of the core issues, development and execution of clear themes in discovery and at trial and more.